当前位置: 首页 > 期刊 > 《中外医学研究》 > 201225
编号:13745929
IDO在卵巢恶性肿瘤中的研究进展(3)
http://www.100md.com 2012年9月5日 《中外医学研究》 201225
     [6] Frumento G,Rotondo R,Tonetti M,et al.Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase[J].J Exp Med,2002,196(4):459-468.

    [7] Muller A J,DuHadaway J B,Donover P S,et al.Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy[J].Nat Med,2005,11(3):312-319.

, 百拇医药     [8] Hou D Y,Muller A J,Sharma M D,et al.Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses[J].Cancer Res,2007,67(2):792-801.

    [9] Muller A J,Scherle P A.Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors[J].Nat Rev Cancer,2006,6(8):613-25.

    [10]陈勇,陈建国,沈洪兵,等.启东1972~2001年恶性肿瘤发病率时间趋势分析[J].疾病控制杂志,2006,10(2):105-108.
, 百拇医药
    [11] Leung B S,Stout L E,Shaskan E G.Differential induction of indoleamine-2,3-dioxygenase (IDO) by interferon-gamma in human gynecologic cancer cells[J].Cancer Lett,1992,66(1):77-81.

    [12] Okamoto A,Nikaido T,Ochiai K,et al.Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells[J].Clin Cancer Res,2005,11(16):6030-6039.

    [13] Takao M,Okamoto A,Nikaido T,et al.Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer[J].Oncol Rep,2007,17(6):1333-1339.
, 百拇医药
    [14] Nonaka H,Saga Y,Fujiwara H,et al.Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion[J]. Oncology,2011,38(1):113-120.

    [15] Munn D H,Sharma M D,Hou D,et al.Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes[J].J Clin Invest,2004,114(2):280-290.

    [16] Sharma M D,Baban B,Chandler P,et al.Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase[J].Clin Invest,2007,117(9):2570-2582.
, 百拇医药
    [17] Della C M,Carlomagno S,Frumento G,et al.The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function[J].Blood,2006,108(13):4118-4125.

    [18] Qian F,Villella J,Wallace P K,et al.Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer[J].Cancer Res,2009,69(13):5498-5504.
, http://www.100md.com
    [19] Yoshida N,Ino K,Ishida Y,et al.Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model[J].Clin Cancer Res,2008,14(22):7251-7259.

    [20] Sun J X,Zhang W G,Chen Y X,et al.Indoleamine 2, 3-dioxygenase expression in cells of human acute monocyte leukemia (M(5)) and acute lymphocyte leukemia and therapeutic effect of its inhibitor 1-methyl tryptophan[J].Journal of experimental hematology,2007,15(3):478-482.

    [21] Cheng T C,Manorek G,Samimi G,et al.Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells[J].Cancer Chemother Pharmacol,2006,58(3):384-395.

    (收稿日期:2012-05-31) (编辑:田烨), http://www.100md.com(王绍佳 杨宏英)
上一页1 2 3